Vitamin D receptor and megalin gene polymorphisms are associated with central adiposity status and changes among US adults

Journal of Nutritional Science

Volumn 2, Issue , 2013, Pages 1-11

  Beydoun, May A ^a   Tanaka, Toshiko ^a   Beydoun, Hind A ^b   Ding, Eric L ^c   Ferrucci, Luigi ^a   Zonderman, Alan B ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adults; Central adiposity; Megalin; SNP; Vitamin D receptor

Indexed keywords

EID: 84944280936     PISSN: 20486790     EISSN: None     Source Type: Journal    
DOI: 10.1017/jns.2013.19     Document Type: Article

References (42)

1. Maes HH, Neale MC & Eaves LJ (1997) Genetic and environmental factors in relative body weight and human adiposity. Behav Genet 27, 325-351.
2. Yang W, Kelly T & He J (2007) Genetic epidemiology of obesity. Epidemiol Rev 29, 49-61.
3. Hunt KJ, Duggirala R, Goring HH, et al. (2002) Genetic basis of variation in carotid artery plaque in the San Antonio Family Heart Study. Stroke 33, 2775-2780.
4. Beydoun MA, Boueiz A, Shroff MR, et al. (2010) Associations among 25-hydroxyvitamin D, diet quality, and metabolic disturbance differ by adiposity in adults in the United States. J Clin Endocrinol Metab 95, 3814-3827.
5. Wortsman J, Matsuoka LY, Chen TC, et al. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690-693.
6. Zemel MB (2003) Role of dietary calcium and dairy products in modulating adiposity. Lipids 38, 139-146.
7. Kato S (2000) The function of vitamin D receptor in vitamin D action. J Biochem 127, 717-722.
8. Wood RJ (2008) Vitamin D and adipogenesis: new molecular insights. Nutr Rev 66, 40-46.
9. Ochs-Balcom HM, Chennamaneni R, Millen AE, et al. (2011) Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr 93, 5-10.
10. Grundberg E, Brandstrom H, Ribom EL, et al. (2004) Genetic variation in the human vitamin D receptor is associated with muscle strength, fat mass and body weight in Swedish women. Eur J Endocrinol 150, 323-328.
11. Filus A, Trzmiel A, Kuliczkowska-Plaksej J, et al. (2008) Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Aging Male 11, 134-139.
12. Oh JY & Barrett-Connor E (2002) Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Metabolism 51, 356-359.
13. Ortlepp JR, Lauscher J, Hoffmann R, et al. (2001) The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med 18, 842-845.
14. Ortlepp JR, Metrikat J, Albrecht M, et al. (2003) The vitamin D receptor gene variant and physical activity predicts fasting glucose levels in healthy young men. Diabet Med 20, 451-454.
15. Speer G, Cseh K, Winkler G, et al. (2001) Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol 144, 385-389.
16. Ye WZ, Reis AF, Dubois-Laforgue D, et al. (2001) Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Eur J Endocrinol 145, 181-186.
17. Gu JM, Xiao WJ, He JW, et al. (2009) Association between VDR and ESR1 gene polymorphisms with bone and obesity phenotypes in Chinese male nuclear families. Acta Pharmacol Sin 30, 1634-1642.
18. Liu W, Yu WR, Carling T, et al. (1998) Regulation of gp330/megalin expression by vitamins A and D. Eur J Clin Invest 28, 100-107.
19. Gressner OA, Lahme B & Gressner AM (2008) Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through Ca2+-dependent interaction with the megalin/gp330 receptor. Clin Chim Acta 390, 28-37.
20. Dietrich MO, Spuch C, Antequera D, et al. (2008) Megalin mediates the transport of leptin across the blood-CSF barrier. Neurobiol Aging 29, 902-912.
21. Matsunuma A & Horiuchi N (2007) Leptin attenuates gene expression for renal 25-hydroxyvitamin D3-1α-hydroxylase in mice via the long form of the leptin receptor. Arch Biochem Biophys 463, 118-127.
22. Lisi S, Segnani C, Mattii L, et al. (2005) Thyroid dysfunction in megalin deficient mice. Mol Cell Endocrinol 236, 43-47.
23. Beydoun MA, Beydoun HA, Shroff MR, et al. (2012) Serum leptin, thyroxine and thyroid-stimulating hormone levels interact to affect cognitive function among US adults: evidence from a large representative survey. Neurobiol Aging 33, 1730-1743.
24. Ding EL, Mehta S, Fawzi WW, et al. (2008) Interaction of estrogen therapy with calcium and vitamin D supplementation on colorectal cancer risk: reanalysis of Women’s Health Initiative randomized trial. Int J Cancer 122, 1690-1694.
25. Heid IM, Jackson AU, Randall JC, et al. (2010) Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 42, 949-960.
26. Beydoun MA, Ding EL, Beydoun HA, et al. (2012) Vitamin D receptor and megalin gene polymorphisms and their associations with longitudinal cognitive change in US adults. Am J Clin Nutr 95, 163-178.
27. Wang Y, Beydoun MA, Liang L, et al. (2008) Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic. Obesity 16, 2323-2330.
28. Shock N, Greulich RC, Andres R, et al. (1984) Normal Human Aging:The Baltimore Longitudinal Study of Aging. Washington, DC: US Government Printing Office.
29. Li Y & Abecasis GR (2006) Mach 1.0: Rapid haplotype reconstruction and missing genotype inference. Am J Hum Genetics S79, 2290.
30. Lanza ST, Collins LM, Lemmon DR, et al. (2007) PROC LCA: a SAS procedure for latent class analysis. Struct Equ Modeling 14, 671-694.
31. Wigginton JE, Cutler DJ & Abecasis GR (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76, 887-893.
32. Hochberg Y & Tamhane AC (1987) Multiple Comparison Procedures. New York: Wiley.
33. Selvin S (2004) Statistical Analysis of Epidemiologic Data, 3rd ed. New York: Oxford University Press.
34. StataCorp LP (2009) Statistics/Data Analysis: Release 11.0. College Station, TX: StataCorp LP.
35. Zmuda JM, Cauley JA & Ferrell RE (2000) Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 22, 203-217.
36. Tworowska-Bardzinska U, Lwow F, Kubicka E, et al. (2008) The vitamin D receptor gene BsmI polymorphism is not associated with anthropometric and biochemical parameters describing metabolic syndrome in postmenopausal women. Gynecol Endocrinol 24, 514-518.
37. Cyganek K, Mirkiewicz-Sieradzka B, Malecki MT, et al. (2006) Clinical risk factors and the role of VDR gene polymorphisms in diabetic retinopathy in Polish type 2 diabetes patients. Acta Diabetol 43, 114-119.
38. Uitterlinden AG, Burger H, Witteman JCM, et al. (1998) Genetic relation between osteoporosis and cardiovascular disease: vitamin D receptor polymorphism predicts myocardial infarction. Osteop Int 8, OR12.
39. Kong J & Li YC (2006) Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 290, E916-E924.
40. Uitterlinden AG, Fang Y, Van Meurs JB, et al. (2004) Genetics and biology of vitamin D receptor polymorphisms. Gene 338, 143-156.
41. Vargas T, Bullido MJ, Martinez-Garcia A, et al. (2010) A megalin polymorphism associated with promoter activity and Alzheimer’s disease risk. Am J Med Genet B Neuropsychiatr Genet 153B, 895-902.
42. Singer JD & Willet JB (editors) (2003) Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press.